WHITTAKER QUANTITATIVE ALPHA TECHNOLOGIES

Pharmaceuticals

95 companies in this sub-industry (Pharmaceuticals, Biotechnology & Life Sciences), largest first. Open any company for its filing-based history.

# Ticker Company Market cap P/E Dividend yield Years of data
1 LLY Eli Lilly and Company $1.04T 41.2 0.5% 12
2 JNJ Johnson & Johnson $602B 28.7 1.1% 12
3 MRK Merck & Company Inc $315B 36.0 2.6% 12
4 NVS Novartis AG ADR $291B 21.9 3.1% 12
5 AZN AstraZeneca PLC $263B 25.6 1.9% 12
6 NVO Novo Nordisk A/S $228B 12.1 3.6% 12
7 PFE Pfizer Inc $143B 18.9 6.9% 12
8 BMY Bristol-Myers Squibb Company $124B 16.9 4.3% 12
9 SNY Sanofi ADR $106B 19.6 0.0% 12
10 GSK GlaxoSmithKline PLC ADR $106B 13.7 3.4% 12
11 TAK Takeda Pharmaceutical Co Ltd ADR $53.4B — 3.8% 12
12 TEVA Teva Pharma Industries Ltd ADR $37.5B 24.0 — 12
13 RPRX Royalty Pharma Plc $33.7B 29.7 1.6% 12
14 ZTS Zoetis Inc $32.2B 12.2 2.7% 12
15 VTRS Viatris Inc $20.2B — 2.9% 12
16 JAZZ Jazz Pharmaceuticals PLC $15.2B 2018.2 — 12
17 ELAN Elanco Animal Health $13B — — 11
18 AXSM Axsome Therapeutics Inc $12.2B — — 12
19 RDY Dr. Reddy’s Laboratories Ltd ADR $10.6B 23.5 0.7% 12
20 CORT Corcept Therapeutics Incorporated $9.86B 262.5 — 12
21 LQDA Liquidia Technologies Inc $6.93B 458.4 — 10
22 DFTX Definium Therapeutics, Inc. $6.25B — — 11
23 AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock $5.43B 46.0 — 12
24 TLX Telix Pharmaceuticals Limited $3.77B — — 12
25 ELVN Enliven Therapeutics Inc. $3.65B — — 9
26 OGN Organon & Co $3.55B 14.5 0.6% 9
27 SUPN Supernus Pharmaceuticals Inc $2.81B — — 12
28 TARS Tarsus Pharmaceuticals Inc $2.54B — — 8
29 TRVI Trevi Therapeutics Inc $2.53B — — 10
30 NKTR Nektar Therapeutics $2.38B — — 12
31 PBH Prestige Brand Holdings Inc $2.32B 12.5 — 12
32 OCUL Ocular Therapeutix Inc $2.23B — — 12
33 HRMY Harmony Biosciences Holdings $2.13B 14.9 — 8
34 RAPP Rapport Therapeutics, Inc. Common Stock $2B — — 4
35 AMLX Amylyx Pharmaceuticals Inc $1.98B — — 7
36 HCM HUTCHMED DRC $1.9B 4.2 — 12
37 ANIP ANI Pharmaceuticals Inc $1.87B 21.0 — 12
38 BHC Bausch Health Companies Inc $1.79B — — 12
39 MAZE Maze Therapeutics, Inc. Common Stock $1.69B — — 4
40 INVA Innoviva Inc $1.64B 3.6 — 12
41 SEPN Septerna, Inc. Common Stock $1.62B — — 4
42 HROW Harrow Health Inc $1.58B — — 12
43 XERS Xeris Pharmaceuticals Inc $1.44B 119.1 — 10
44 PRGO Perrigo Company PLC $1.41B — 11.1% 12
45 PAHC Phibro Animal Health Corporation $1.3B 13.8 1.5% 12
46 EYPT EyePoint, Inc $1.23B — — 12
47 WVE Wave Life Sciences Ltd $1.2B — — 12
48 COLL Collegium Pharmaceutical Inc $1.14B 17.1 — 12
49 BIOA BioAge Labs, Inc $1.08B — — 9
50 CRON Cronos Group Inc $1.03B — — 12
51 PHAT Phathom Pharmaceuticals Inc $1.01B — — 8
52 ETON Eton Pharmaceuticals Inc $1B — — 9
53 PCRX Pacira BioSciences, Inc. $1B 196.0 — 12
54 LBRX LB Pharmaceuticals Inc Common Stock $945M — — 4
55 ANRO Alto Neuroscience, Inc. $941M — — 5
56 TBPH Theravance Biopharma Inc $877M 7.6 — 12
57 AMPH Amphastar P $825M 11.3 — 12
58 ACRS Aclaris Therapeutics Inc $779M — — 12
59 OMER Omeros Corporation $740M 9.0 — 12
60 RLMD Relmada Therapeutics Inc $673M — — 12
61 CRMD CorMedix Inc $659M 3.9 — 12
62 CTNM Contineum Therapeutics, Inc. Class A Common Stock $578M — — 5
63 TLRY Tilray Inc $546M — — 12
64 ARVN Arvinas Inc $534M — — 10
65 AQST Aquestive Therapeutics Inc $517M — — 12
66 CGC Canopy Growth Corp $436M — — 12
67 EOLS Evolus Inc $435M — — 11
68 HELP Cybin Inc. Common Stock $404M — — 10
69 AVIR Atea Pharmaceuticals Inc $399M — — 8
70 SNDL SNDL Inc. $341M — — 10
71 IRD Opus Genetics, Inc. $339M — — 7
72 NMRA Neumora Therapeutics, Inc. $306M — — 7
73 SIGA SIGA Technologies Inc $257M 12.8 0.0% 12
74 SLGL Sol Gel Technologies Ltd $242M — — 12
75 FULC Fulcrum Therapeutics Inc $233M — — 9
76 MDWD Mediwound Ltd $184M — — 12
77 ACB Aurora Cannabis Inc $168M — — 12
78 ORMP Oramed Pharmaceuticals Inc $165M 1.6 0.0% 12
79 MIST Milestone Pharmaceuticals Inc $159M — — 9
80 ASRT Assertio Therapeutics Inc $152M — — 12
81 OGI OrganiGram Holdings Inc $136M — — 12
82 BGM Qilian International Holding Group Limited $134M — — 8
83 AARD Aardvark Therapeutics, Inc. Common Stock $133M — — 4
84 ALTS ALT5 Sigma Corporation $120M — — 6
85 NTHI NeOnc Technologies Holdings, Inc. Common Stock $116M — — 5
86 VRCA Verrica Pharmaceuticals Inc $108M — — 10
87 PTHS Pelthos Therapeutics Inc. $92.8M — — 6
88 ELTX Elicio Therapeutics Inc. $91.4M — — 10
89 LONA LeonaBio, Inc. $90.2M — — 8
90 CPIX Cumberland Pharmaceuticals Inc $88.8M — — 12
91 TELO Telomir Pharmaceuticals, Inc. Common Stock $84.9M — — 5
92 KG Kestrel Group, Ltd. $80.3M 1.9 — 12
93 TLPH Talphera Inc. $73.4M — — 12
94 SCLX Scilex Holding Company $66.7M — — 7
95 CNTX Context Therapeutics Inc $60M — — 9

Market capitalization, P/E and dividend yield are the published company index's values as of 2026-07-22. Sorted by size; this is not a ranking of quality.

Other Health Care sub-industries